CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO Perspective
2.2 Market beyond: what to expect by 2027 ($million)
2.2.1 Moderate Growth Scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.3 Government regulations
3.3.1 U.S. FDA
3.3.2 Europe CE Mark
3.3.3 Ministry of Health, Labour and Welfare (MHLW)
3.4 Reimbursement scenarios
3.5 Porter's five forces analysis
3.5.1 Low bargaining power of suppliers
3.5.2 Moderate bargaining power of buyers
3.5.3 Low threat of new entrants
3.5.4 Low threat of substitutes
3.5.5 Moderate competitive rivalry
3.6 Clinical trials
3.7 Patent analysis
3.7.1 China: Patent Analysis by Market Participants
3.7.2 The U.S.: Patent Analysis by Market Participants
3.7.3 Europe: patent analysis, by market participant
3.7.4 Canada: patent analysis, by market participant
3.7.5 Others: Patent Analysis, by Market Participant
3.8 Top player positioning, 2015
3.9 Top impacting factors
3.9.1 Drivers
3.9.1.1 Rise in the prevalence of cancer and cardiac diseases
3.9.1.2 Increase in the number of patients suffering from pain
3.9.1.3 High efficacy and short duration of the procedure
3.9.2 Restrains
3.9.2.1 High cost of treatment
3.9.2.2 Limited awareness
3.9.2.3 Availability of other treatments
3.9.3 Opportunities
3.9.3.1 Lucrative opportunities in emerging markets
3.9.3.2 Untapped RFA market opportunity
3.9.3.3 Recent advancements
CHAPTER 4 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY APPLICATION
4.1 Overview
4.1.1 Market size and forecast
4.2 Cardiology
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 Irrigated-tip RF ablation catheters
4.2.5 Conventional RF ablation catheters
4.3 Oncology
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.3.4 Breast cancer
4.3.5 Colorectal cancer
4.3.6 Lung cancer
4.3.7 Prostate cancer
4.3.8 Liver cancer
4.3.9 Kidney cancer
4.3.10 Spinal metastases
4.3.11 Other cancers
4.4 Pain management
4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
4.4.4 Neck pain
4.4.5 Shoulder pain
4.4.6 Upper back pain
4.4.7 Lower back pain
4.4.8 Knee pain
4.4.9 Other pain syndromes
CHAPTER 5 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY PRODUCT TYPE
5.1 Overview
5.1.1 Market size and forecast
5.2 Devices
5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.3 Disposables
5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast
CHAPTER 6 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY GEOGRAPHY
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.2.4 U.S. market size & forecast
6.2.5 Canada market size & forecast
6.2.6 Mexico market size & forecast
6.3 Europe
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.3.4 Germany market size & forecast
6.3.5 France market size & forecast
6.3.6 U.K. market size & forecast
6.3.7 Italy market size & forecast
6.3.8 Spain market size & forecast
6.3.9 Russia market size & forecast
6.3.10 Rest of Europe market size & forecast
6.4 Asia-Pacific
6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.4.4 Japan market size & forecast
6.4.5 China market size & forecast
6.4.6 Australia market size & forecast
6.4.7 India market size & forecast
6.4.8 South Korea market size & forecast
6.4.9 Taiwan market size & forecast
6.4.10 Rest of Asia Pacific market size & forecast
6.5 Latin America, Middle East, Africa (LAMEA)
6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
6.5.4 Brazil market size & forecast
6.5.5 Turkey market size & forecast
6.5.6 Venezuela market size & forecast
6.5.7 Saudi Arabia market size & forecast
6.5.8 Republic of South Africa market size & forecast
6.5.9 Rest of LAMEA market size & forecast
CHAPTER 7 COMPANY PROFILES
7.1 Halyard Health, Inc.
7.1.1 Company overview
7.1.2 Operating business segments
7.1.3 Business performance
7.2 Stryker Corporation
7.2.1 Company overview
7.2.2 Operating business segments
7.2.3 Business performance
7.2.4 Key strategic moves & developments
7.3 St. Jude Medical, Inc.
7.3.1 Company overview
7.3.2 Operating business segments
7.3.3 Business performance
7.3.4 Key strategic moves & developments
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Operating business segments
7.4.3 Business performance
7.4.4 Key strategic moves & developments
7.5 Boston Scientific Corporation
7.5.1 Company overview
7.5.2 Operating business segments
7.5.3 Business performance
7.5.4 Key strategic moves & developments
7.6 C. R. Bard, Inc.
7.6.1 Company overview
7.6.2 Operating business segments
7.6.3 Business performance
7.6.4 Key strategic moves & developments
7.7 AngioDynamics, Inc.
7.7.1 Company overview
7.7.2 Operating business segments
7.7.3 Business performance
7.7.4 Key strategic moves & developments
7.8 Hologic, Inc.
7.8.1 Company overview
7.8.2 Operating business segments
7.8.3 Business performance
7.8.4 Key strategic moves & developments
7.9 AtriCure, Inc.
7.9.1 Company overview
7.9.2 Operating business segments
7.9.3 Business performance
7.9.4 Key strategic moves & developments
7.10 Johnson and Johnson
7.10.1 Company overview
7.10.2 Operating business segments
7.10.3 Business performance
7.10.4 Key Strategic moves & developments
*Other players in the value chain include
Baylis Medical
Arthrex, Inc.
inomed Medizintechnik GmbH
Sutter Medizintechnik GmbH
Bramsys Indstria e Comrcio Ltda
ENDO-FLEX GmbH
Epimed International
sfm medical devices GmbH
*Profiles of these players are not included. The same will be included on request.